Blog BPC-157 peptide therapy BPC-157 Peptide Therapy: A Grounded Look at the Research BPC-157 peptide therapy comes up often in conversations about recovery and tissue repair
Common Mild Side Effects These typically appear during the first few weeks of use: Increased hunger Especially with Ipamorelin due to ghrelin receptor stimulation Mild water retention Often resolves after the body adjusts Tingling or numbness Usually in fingers or hands (transient) Lightheadedness More common with higher doses or low-carb diets Most of these effects are dose-dependent and subside within a week or two
This inherent stability allows it to remain biologically active for extended periods, a characteristic that makes it suitable for oral administration in research settings, particularly for studies focused on gastrointestinal health
Gentle complex carbohydrates in small portions (oatmeal, sweet potato, legumes) provide energy for exercise and support gut motility
Instead, it means we refrain from incorporating mystery additives or undisclosed fragrances to mask the inherent smell of GHK-Cu Copper Peptide
Pediatrics 133 , 872883 (2014)